Melatonin MT1 receptor effectively inhibited the expression of integrin α2β1 and the transcriptional activities of FAK, C-SRC, and NF-κB, thereby reducing the migration and invasion ability of prostate cancer cells [143]. The gene discussed is NFKB1; the disease is prostate cancer.